Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Breastmilk and Serum Exosome Profile in Prediction of the Severity and Treatment Requirement of Neonatal Jaundice Due to ABO Incompatibility

NCT06502847 is registered in ClinicalTrials.gov with Kanuni Sultan Suleyman Training and Research Hospital as lead sponsor.

NCT NCT06502847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06502847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Breastmilk and Serum Exosome Profile in Prediction of the Severity and Treatment Requirement of Neonatal Jaundice Due to ABO Incompatibility
Lead sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2020
Completion date
June 1, 2023
Enrollment
338 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abo hemolytic disease, abo incompatibility, neonatal jaundice from other specified causes